Best EHR for naturopathic and functional medicine in 2026: a sourced scorecard with the rubric attached

The "best EHR for naturopathic doctors" question gets asked constantly in private forums, in AANP threads, in IFM Slack rooms, and on Reddit. The answers tend to come in two flavours. The first flavour is a listicle on a comparison site that reads like the seven vendor about-pages stitched end-to-end with a paragraph break between them. The second flavour is the vendor's own competitive page, which is usually sharp and well-researched and also obviously sponsored by exactly one of the seven.

Neither one tells a working clinician what they need to know.

So I built a rubric. Ten criteria, weighted equally. I scored seven vendors against it using their public pricing pages, their own integration documentation, third-party software directories, the Cerbo and OptiMantra merger announcement from December 3, 2025, and a stack of Capterra reviews. Disclosure up front: this scorecard is published on Oli Health's blog, and Oli is one of the seven vendors being scored. OptiMantra leads the table at 22/30; Cerbo and Oli sit one point behind at 21/30. That is the most generous reading the rubric allows, and the credibility of an honest scorecard depends on the publishing vendor losing real categories. Oli trails Cerbo on the lab-integration column where 60+ native integrations is best-in-class by a wide margin, trails Power2Practice on IV procedure depth where its dedicated IV workflow is the specific depth play, and trails OptiMantra on cash-pay revenue model and multi-disciplinary support. The IFM matrix renderer isn't a column in this rubric, but it's a real product gap and only Living Matrix licenses it — flagged in the Oli narrative below.

What follows is the table, the criteria, the seven vendor narratives, and the math on what a one-practitioner clinic ends up paying. If you're shortlisting two or three EHRs this quarter, the cost table at the bottom is probably the part you came for.

Who's in the comparison, and who isn't

Seven vendors meet the bar of being a real EHR or chart-adjacent platform with documented adoption inside US naturopathic and functional medicine practices: Cerbo (formerly MD HQ), Practice Better, OptiMantra, ChARM Health, Living Matrix, Power2Practice, and Oli Health.

A handful of names that get suggested in forums are not in the table, and the reason matters.

SimplePractice, Jane App, Carepatron, DrChrono, Tebra, and Practice Fusion are generalist allied-health or insurance-billing EHRs. Useful tools, wrong shape for the longitudinal-labs-and-supplements clinical model. We covered the architectural mismatch in a separate piece on naturopathic vs generalist software. Vibrant Practice EHR launched in January 2026 and there isn't a public adoption signal yet — interesting, but too early to grade. Healthie leans nutrition and coaching; Cerbo's competitive page describes nutrition-and-coaching platforms as lacking deeper FM-specific tooling (worth flagging — that's a competitor's framing, not a neutral source). Praxis EMR claims to be the "best EHR for naturopathic medicine" but its third-party traction in this vertical is thin. NaturoMedic, NaturalCRM, HealOS, Heal.me, and HealthArc came up in research and could not be verified as real US ND-EHR vendors with active customers; mention them so a reader doesn't waste an afternoon.

The rubric, ten criteria

Each vendor is scored 0–3 on the ten criteria below. 0 = not available or a serious gap; 1 = partial or token-capped; 2 = available and functional; 3 = available and best-in-class.

The criteria, in plain English: (1) functional lab integrations — DUTCH, GI-MAP, OAT, Genova, Vibrant, Mosaic, Doctor's Data, ZRT, Rupa, Evexia. (2) supplement workflow — Fullscript / Emerson / Wellevate, brand, dose, schedule, taper, adherence. (3) longitudinal chart synthesis — multi-year timeline, AI overview, plain-English chart search. (4) IV therapy and procedure depth — lot/batch, drip rate, infusion timer, consent linkage. (5) cash-pay revenue model — packages, memberships, dispensary margin, sliding scale. (6) multi-disciplinary support — specialty templates feeding one shared chart, role-based access. (7) AI capability — scribe, intake, overview, OCR, with depth, not just presence. (8) pricing transparency and total cost — including add-ons and setup, normalised to one practitioner. (9) onboarding and support — setup time, training, fees per customisation. (10) honest gaps and risk factors — data loss, dated UI, terminology rigidity, mixed reviews.

The master scoring table

Verified April 2026.

A few things the table tells you that no marketing page will.

OptiMantra leads the top total at 22/30. Cerbo and Oli tie one point behind at 21/30, for different reasons: Cerbo on labs, supplement workflow, and direct-pay clinic depth; Oli on AI capability, longitudinal chart synthesis, and pricing transparency. Power2Practice owns IV depth at 3, the only column where its purpose-built infusion stack is best-in-class. Living Matrix scores an 8 because it isn't a full EHR; it's an intake-and-matrix layer that you put on top of one. The table treats it like an EHR for honesty, but the right reading of that 8 is "this product solves a different problem." More on that in its narrative below.

Reading the categories before reading the vendors

A few of the criterion scores deserve an extra sentence or two so you can interpret what a 2 versus a 3 means in this rubric.

Lab depth: Cerbo's 60+ electronic lab integrations is best-in-class by a clear margin; nobody else publishes a list at that scale. Practice Better's competitive page from Cerbo (flagged as biased, though the underlying claim is verifiable in Practice Better's own docs) names Rupa and Evexia as the lab partners. Adequate for clinics that route everything through Rupa, thin if you order direct from DUTCH or Genova. Supplement workflow: native Fullscript, Emerson, and Wellevate plus dispensary lot/expiry is the high bar. Most vendors hit Fullscript and stop there. AI: Oli runs OCR on every uploaded PDF (lab values become structured data, trendable across vendors), an AI patient overview that synthesises labs, intake, and prior notes into a one-screen pre-visit brief, and a scribe and intake. OptiMantra has Deep Cura, which earns partial credit because it is an integration rather than a full native AI layer. Practice Better has AI charting. Cerbo has partner integrations but does not advertise a single AI pipeline. IV depth: Power2Practice's IV therapy workflow is the best in the category for high-volume IV clinics. Pricing transparency: Cerbo and OptiMantra publish prices on the site; Living Matrix and Power2Practice gate behind quote forms; ChARM publishes per-encounter; Oli is flat $19.95/mo on the site. Honest gaps: this column credits vendors for not having serious published red flags such as recurring data-loss reports, a dated UI complaint pattern, terminology rigidity, or roadmap blockers.

Seven vendors, shortlisted

Cerbo (formerly MD HQ) — total 21/30

Cerbo is the most clinically deep functional-medicine-purpose-built EHR in the US market and has been since the MD HQ rebrand. It claims 5,000+ practitioners (self-reported on the homepage; flagged as such, though directionally correct), 60+ lab integrations, Fullscript / Emerson / Wellevate dispensary with lot/expiry, BHRT and IV support, and a charting model designed around the longer naturopathic visit. Best for an established clinic that orders direct from a long tail of specialty labs and has $300/mo per prescribing practitioner in the budget.

Pricing (verified April 2026): Prescribing FT $281, PT $174; Non-Prescribing FT $256, PT $160; Supporting (LAc, RD, DC) FT $127, PT $78. Setup $1,195, or $595 for new micro-practices. Patient Portal $79/mo. Telemedicine $27–$39/mo per provider. The total cost on a labs-heavy 1-practitioner clinic with portal and telemed is roughly $400/mo recurring, or close to $500/mo year one once the $1,195 setup is amortised across twelve months.

The gaps are not financial. Capterra reviews flag a recurring UI complaint pattern. One practice manager (October 2024) reported a "complete loss of data for our clinic." A February 2024 owner reported paying "$2,300 in setup" and being "never trained." A 2024 nurse practitioner reported "they charge a fee for every small customization you want." A July 2024 owner used a phrase I'll let speak for itself further down the article.

Practice Better — total 16/30

Practice Better is the wellness-and-coaching-leaning platform with the strongest patient portal experience in the table, comprehensive program-builder for protocols, and Fullscript dispensary integration. Best for nutrition-leaning, coaching-heavy practices that don't run a long tail of specialty labs. The Cerbo competitive page describes Practice Better as "remain[ing] built for coaching workflows rather than comprehensive patient management." Directionally accurate, but the source is a competitor and reads as such.

Pricing (verified April 2026): Starter $25/mo annual or $35/mo monthly; Professional $69; Plus $99; Team $155. AI charting first 600 minutes free, then $0.60/hr. ePrescribe $49/mo + $99 onboarding. SMS $0.05/text, fax $0.10/page.

The honest gaps: lab depth is documented as Rupa + Evexia. Adequate for the Rupa-routed practice, thin if you order direct. A Capterra reviewer (3/5 stars) reported telehealth glitches "forced rescheduling 2 patients worth $350 in 4 days." Small sample, but the pattern recurs across multiple reviews on the same listing. The score reflects the full picture, not the marketing one.

OptiMantra — total 22/30

OptiMantra is the best multi-modality integrative platform in the comparison. Strong dispensary with point-of-sale, native multi-disciplinary support across ND/DC/LAc/RD, published transparent pricing, and a Deep Cura AI integration on the same pricing page. Cerbo and OptiMantra merged on December 3, 2025 under CEO Jeff Hindman; the products remain operationally separate today, but the strategic story is now Cerbo/OptiMantra (consolidated) versus everyone else.

Pricing (verified April 2026): Base $99/mo, additional practitioners $49, clinical staff $25. eRx with EPCS $38/mo. Insurance billing $0.25 per claim. Discounts of 50% (student), 30% (PT), 20% (NP/PA). Software Finder estimates initial setup at $1,000–$10,000 depending on practice size and complexity. That's third-party data; OptiMantra's own pricing page does not disclose setup, which is a fair-use criticism.

Best for an integrative clinic with two to five practitioners across modalities running a real dispensary.

ChARM Health — total 15/30

ChARM is the cheapest credible option for a low-volume practice. Its official pricing page lists a free plan up to 50 encounters, an Encounter Plan at $0.50 per encounter with a $25 monthly minimum, and a Provider Plan at $200/mo. Native Fullscript integration. A published naturopathic case study makes the ND positioning credible.

The trade-off: ChARM is functionally a generalist with an FM template skin. The chart synthesis, lab depth, and procedure interface aren't FM-purpose-built. Best for a low-volume solo practice early in its build, or for a part-time clinician who wants something working for under $50/mo.

Living Matrix — total 8/30

Living Matrix is not an EHR. It is an intake-and-matrix tool built around the IFM functional medicine matrix and timeline workflow. It does not do scheduling, billing, telehealth, or multi-disciplinary charting; it isn't trying to. The 8/30 reflects scoring it like the others, but the right reading is "Living Matrix solves one problem extremely well and you layer it on top of an EHR."

Pricing per a 2019 ND review by Camille Freeman ND: roughly $129/mo or $1,393/yr plus $245 setup. Current pricing isn't published on the public site, so the 2019 number is the most recent verifiable figure. Use it as directional. Camille's review also flagged terminology rigidity ("hard-coded patient and prescription") that exposes non-prescribing wellness-state practitioners to language risk, and intake forms that take "30–90 minutes" for clients to complete. If you train under IFM and the visual matrix is non-negotiable, Living Matrix is the only product that ships it. Pair it with Cerbo or OptiMantra (or with Oli, where the AI patient overview synthesises the same multi-system pattern in a different format).

Power2Practice — total 16/30

Power2Practice is the IV-therapy and anti-aging-leaning EHR with A4M endorsement and a dedicated IV therapy workflow. For a clinic running 20+ IV procedures a day, this is the first platform in the table to examine.

Pricing is gated behind a quote form on the public site; Software Advice lists $199/mo as the starting price. Slashdot reviews skew mixed (small sample, flag accordingly). The UI is older than the rest of the field and the support footprint is thinner than Cerbo's. The 16 reflects best-in-class IV depth being weighted equally with eight other criteria where the platform is mid-tier or thin.

Oli Health — total 21/30

Oli is the AI-first EHR publishing this scorecard. Conversational intake, OCR on every uploaded lab PDF (Azure Document Intelligence), an AI patient overview that synthesises labs and prior notes into a one-screen pre-visit brief, an AI scribe, scheduling, recurring billing with memberships and payment plans, telehealth, client portal, integrated billing and invoicing, and superbills — all included for $19.95/mo flat, one price for all features and all practitioners. No setup fee. No per-add-on charges. Insurance verification, claims management, and ERA processing are marked coming soon on the pricing feature matrix, so they are not scored as live features here.

The gaps I'm scoring honestly: e-prescribe is on the roadmap and not in the product yet, which is a hard block for ND practices that prescribe controlled substances in a state that allows it. IV procedure depth scores 2, not 3 — drip-rate prompts, lot/batch, infusion timer, and consent linkage are in place, and a small library of pre-built protocols ships, but Power2Practice's 30+ purpose-built infusion protocols are not at parity. Native IFM matrix renderer: only Living Matrix has this, by license; the AI overview surfaces the same multi-system pattern from a different angle. Supplement-supplement and supplement-drug interaction checking is not built in — manual review remains required, and so far as I can tell from public documentation, neither does Cerbo at the depth a clinical pharmacist would want; I'm calling Oli's gap because the disclosure obligation is on the publishing vendor.

The 23 reflects all of that. Best for solo and small ND/FM practices that want the AI workflow at a flat fee — including cash-pay clinics, hybrid clinics that bill some insurance, and integrative practices that need recurring memberships, packages, and superbills running alongside electronic claims.

The Capterra reviews are the most consistent source of independent-of-vendor signal in this space. Use them as a triangulation tool, not as the only data point.

What one practitioner ends up paying, six months in

The next table normalises all seven vendors to a one-practitioner ND practice running for six months, with the add-ons most labs-heavy clinics need (portal, telehealth, eRx where available, claims module where in-product). Setup fees are amortised across year one (twelve months).

The distribution is bimodal. ChARM and Oli sit in the $20–$50 band; everyone else is in the $140–$500 band. Cerbo's price point is real and it buys real depth. It's the only EHR in the table that ships 60+ native lab integrations. The cost difference matters most to practices running closest to the operating margin, which is more of them than the marketing pages assume. The AANP solo income data (2012 survey, dated, flag) reported a median solo ND income around $75K. There's a real ceiling on what a solo practice in a tight cash-pay vertical can spend on software, regardless of how much it would help.

Why pricing transparency matters more than it should

Cerbo and OptiMantra publish full prices on their site. Practice Better publishes tiers and add-ons. ChARM publishes per-encounter rates. Oli publishes one number. Living Matrix and Power2Practice gate everything behind a quote form, which is the second-loudest signal a vendor sends about how its sales process works. (The loudest is whether their pricing page says "starting at." Power2Practice's does.)

Quote-only pricing is not, by itself, a flaw. It can mean the right price for a clinic depends on configuration, and the vendor would rather have a conversation than publish a misleading floor. It can also mean the price varies based on what the prospect appears willing to pay. The ND community's whisper network is the only realistic check on the second possibility. When six prospects compare quotes for the same configuration and the spread is more than 30%, that tells you something.

The spread on this table from $19.95/mo (Oli, flat) to roughly $500/mo (Cerbo with add-ons amortised across year one) is not a like-for-like comparison and I'm not going to pretend it is. Cerbo includes 60+ lab integrations and dispensary lot/expiry; Oli doesn't have either at that depth. The point of publishing the spread is that a clinic should know the spread before it picks the vendor, not after the contract is signed and the setup invoice arrives.

Why Cerbo leads on labs and why Oli still has a place in the table

Cerbo is the clinical-depth leader in this category and that is not a courtesy ranking. The 60+ lab integrations is the single largest published list in the comparison; it's been built over years; it covers exactly the long-tail vendors a labs-heavy ND practice cares about. If a clinic has $300+/mo per prescribing practitioner in the budget, the chart-side complexity tolerance to learn an older interface, and a strong administrative function to manage Cerbo's per-customisation fee structure, Cerbo is a serious choice and the right one for many established practices.

Why does Oli land on this table at all then? Three reasons that are independent of Cerbo's quality. First, Cerbo's price point excludes a real segment of solo NDs (see the AANP solo income data above). A median solo ND clinic operating near margin can't carry $300+/mo for an EHR before they've billed their first patient. Second, the Capterra UI complaint pattern is recurring and not isolated to one reviewer. Third, AI as a clinical category has shifted what an EHR can do (conversational intake, OCR-extracted lab data, AI patient overview, scribe), and shipping those into a Cerbo-shaped legacy product is a different engineering project than building from the AI workflow outward, which is what Oli did.

Both can be true. Cerbo is the clinical-depth leader on labs and supplement workflow. Oli is the AI-first runner-up on the consolidated rubric and the flat-fee floor of the price band. A clinic should pick on its real constraints, not on whichever vendor has the louder marketing page.

Why Oli scores 23, not 30

Eight is the score Living Matrix receives against a full-EHR rubric it never set out to satisfy. Twenty-one is the highest score Oli should honestly receive in April 2026 — tied with Cerbo and behind OptiMantra. Naming the gaps is how a scorecard earns the right to be cited.

Oli's gaps, as of this article: e-prescribe is on the roadmap and not in the product yet — a clinic that prescribes controlled substances today is blocked. IV procedure depth is functional but not Power2Practice-equivalent; the four core elements (lot/batch, drip-rate prompts, infusion timer, consent linkage) are in place, but Power2Practice's dedicated IV workflow and protocol depth are not at parity. Native IFM matrix rendering is Living Matrix's territory by license; the AI patient overview synthesises the same multi-system pattern, but a clinician who specifically wants the visual matrix should layer Living Matrix on top of Oli. Supplement-supplement and supplement-drug interaction checking is not built in; manual clinical review remains required. The lab-integration count is real-but-not-best-in-class — OCR on every uploaded PDF gives cross-vendor trending out of the box, but it does not match Cerbo's 60+ direct electronic interfaces for clinics that want zero PDF handling.

Saying that plainly is the price of admission to a real comparison table. Vendors that close gaps will earn higher scores in any future review; this one included.

A note on dating, not a verdict

This scorecard is dated April 2026 because anything else would be dishonest. Cerbo and OptiMantra finished merging four months ago and the integrated product roadmap is still settling. Practice Better's AI charting tier is six months old. Oli's e-prescribe is shipping later this year. Treat the table as a snapshot of public sources at the date stamped on it.

If you're a solo or small ND/FM clinic in active vendor evaluation, the practical move is: shortlist on the two or three categories that matter most for your model (labs-heavy → Cerbo or OptiMantra; cash-pay multi-modality with dispensary → OptiMantra; IV-heavy → Power2Practice; AI-first at flat fee, with recurring billing and superbills now and claims/ERA still coming soon → Oli; coaching-leaning → Practice Better; budget-constrained low-volume → ChARM; IFM matrix non-negotiable → Living Matrix on top of one of the above), then run a parallel trial for 30 days before migrating any data. Most of the vendors on this list offer that.

Frequently asked questions